Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vascular targeting and antigen presentation.

Literature DB >> 11429533

Vascular targeting and antigen presentation.

R Pasqualini, D M McDonald, W Arap.

Abstract

Mesh：

Year: 2001 PMID： 11429533 DOI： 10.1038/89704

Source DB: PubMed Journal: Nat Immunol ISSN： 1529-2908 Impact factor: 25.606

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Endothelial nanomedicine for the treatment of pulmonary disease.

Authors: Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal: Expert Opin Drug Deliv Date: 2014-11-14 Impact factor: 6.648

2. Endothelial targeting of antibody-decorated polymeric filomicelles.

Authors: Vladimir V Shuvaev; Marc A Ilies; Eric Simone; Sergei Zaitsev; Younghoon Kim; Shenshen Cai; Abdullah Mahmud; Thomas Dziubla; Silvia Muro; Dennis E Discher; Vladimir R Muzykantov
Journal: ACS Nano Date: 2011-08-23 Impact factor: 15.881

Review 3. Targeted endothelial nanomedicine for common acute pathological conditions.

Authors: Vladimir V Shuvaev; Jacob S Brenner; Vladimir R Muzykantov
Journal: J Control Release Date: 2015-10-03 Impact factor: 9.776

4. Modulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates.

Authors: Vladimir V Shuvaev; Samira Tliba; Jeremy Pick; Evguenia Arguiri; Melpo Christofidou-Solomidou; Steven M Albelda; Vladimir R Muzykantov
Journal: J Control Release Date: 2010-10-31 Impact factor: 9.776

5. Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.

Authors: Elizabeth D Hood; Colin F Greineder; Chandra Dodia; Jingyan Han; Clementina Mesaros; Vladimir V Shuvaev; Ian A Blair; Aron B Fisher; Vladimir R Muzykantov
Journal: J Control Release Date: 2012-09-06 Impact factor: 9.776

Vascular targeting and antigen presentation.

Review 1. Endothelial nanomedicine for the treatment of pulmonary disease.

2. Endothelial targeting of antibody-decorated polymeric filomicelles.

Review 3. Targeted endothelial nanomedicine for common acute pathological conditions.

4. Modulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates.

5. Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.

Review 6. Targeting therapeutics to endothelium: are we there yet?

7. Targeted modulation of reactive oxygen species in the vascular endothelium.

Review 8. Targeted interception of signaling reactive oxygen species in the vascular endothelium.

9. Biodistribution of filamentous phage peptide libraries in mice.

Review 10. Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm.